Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guideline Article Swipe
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1111/obr.13704
Summary This systematic review and meta‐analysis evaluated the efficacy of anti‐obesity agents for hormonal, reproductive, metabolic, and psychological outcomes in polycystic ovary syndrome (PCOS) to inform the 2023 update of the International Evidence‐based Guideline on PCOS. We searched Medline, EMBASE, PsycInfo, and CINAHL until July 2022 with a 10‐year limit to focus on newer agents. Eleven trials (545 and 451 participants in intervention and control arms respectively, 12 comparisons) were included. On descriptive analyses, most agents improved anthropometric outcomes; liraglutide, semaglutide and orlistat appeared superior to placebo for anthropometric outcomes. Meta‐analyses were possible for two comparisons (exenatide vs. metformin and orlistat + combined oral contraceptive pill [COCP] vs. COCP alone). On meta‐analysis, no differences were identified between exenatide versus metformin for anthropometric, biochemical hyperandrogenism, and metabolic outcomes, other than lower fasting blood glucose more with metformin than exenatide (MD: 0.10 mmol/L, CI 0.02–0.17, I 2 = 18%, 2 trials). Orlistat + COCP did not improve metabolic outcomes compared with COCP alone (fasting insulin MD: −8.65 pmol/L, −33.55 to 16.26, I 2 = 67%, 2 trials). Published data examining the effects of anti‐obesity agents in women with PCOS are very limited. The role of these agents in PCOS should be a high priority for future research.
Related Topics
- Type
- review
- Language
- en
- Landing Page
- https://doi.org/10.1111/obr.13704
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704
- OA Status
- hybrid
- Cited By
- 30
- References
- 61
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4391837998
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4391837998Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/obr.13704Digital Object Identifier
- Title
-
Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guidelineWork title
- Type
-
reviewOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-02-14Full publication date if available
- Authors
-
Alyse S. Goldberg, Sandro Graca, Jing Liu, Vibhuti Rao, Selma F. Witchel, Alexia Peña, Rong Li, Aya Mousa, Chau Thien Tay, Loyal Pattuwage, Helena Teede, Bülent Okan Yıldız, Carolyn EeList of authors in order
- Landing page
-
https://doi.org/10.1111/obr.13704Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704Direct OA link when available
- Concepts
-
Medicine, Orlistat, Polycystic ovary, Exenatide, Metformin, Liraglutide, Internal medicine, Meta-analysis, Sitagliptin, Endocrinology, Insulin resistance, Obesity, Weight loss, Type 2 diabetes, Insulin, Diabetes mellitusTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
30Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 23, 2024: 7Per-year citation counts (last 5 years)
- References (count)
-
61Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4391837998 |
|---|---|
| doi | https://doi.org/10.1111/obr.13704 |
| ids.doi | https://doi.org/10.1111/obr.13704 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38355887 |
| ids.openalex | https://openalex.org/W4391837998 |
| fwci | 34.57371651 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D005260 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Female |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | Q000188 |
| mesh[2].descriptor_ui | D011085 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug therapy |
| mesh[2].descriptor_name | Polycystic Ovary Syndrome |
| mesh[3].qualifier_ui | Q000627 |
| mesh[3].descriptor_ui | D019440 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | therapeutic use |
| mesh[3].descriptor_name | Anti-Obesity Agents |
| mesh[4].qualifier_ui | Q000627 |
| mesh[4].descriptor_ui | D003277 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | therapeutic use |
| mesh[4].descriptor_name | Contraceptives, Oral, Combined |
| mesh[5].qualifier_ui | Q000627 |
| mesh[5].descriptor_ui | D000077403 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | therapeutic use |
| mesh[5].descriptor_name | Orlistat |
| mesh[6].qualifier_ui | Q000627 |
| mesh[6].descriptor_ui | D000077270 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | therapeutic use |
| mesh[6].descriptor_name | Exenatide |
| mesh[7].qualifier_ui | Q000627 |
| mesh[7].descriptor_ui | D008687 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | therapeutic use |
| mesh[7].descriptor_name | Metformin |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D007004 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Hypoglycemic Agents |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D005260 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Female |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D006801 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Humans |
| mesh[11].qualifier_ui | Q000188 |
| mesh[11].descriptor_ui | D011085 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | drug therapy |
| mesh[11].descriptor_name | Polycystic Ovary Syndrome |
| mesh[12].qualifier_ui | Q000627 |
| mesh[12].descriptor_ui | D019440 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | therapeutic use |
| mesh[12].descriptor_name | Anti-Obesity Agents |
| mesh[13].qualifier_ui | Q000627 |
| mesh[13].descriptor_ui | D003277 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | therapeutic use |
| mesh[13].descriptor_name | Contraceptives, Oral, Combined |
| mesh[14].qualifier_ui | Q000627 |
| mesh[14].descriptor_ui | D000077403 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | therapeutic use |
| mesh[14].descriptor_name | Orlistat |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D000077270 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Exenatide |
| mesh[16].qualifier_ui | Q000627 |
| mesh[16].descriptor_ui | D008687 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | therapeutic use |
| mesh[16].descriptor_name | Metformin |
| mesh[17].qualifier_ui | Q000627 |
| mesh[17].descriptor_ui | D007004 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | therapeutic use |
| mesh[17].descriptor_name | Hypoglycemic Agents |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D005260 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Female |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000188 |
| mesh[20].descriptor_ui | D011085 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | drug therapy |
| mesh[20].descriptor_name | Polycystic Ovary Syndrome |
| mesh[21].qualifier_ui | Q000627 |
| mesh[21].descriptor_ui | D019440 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | therapeutic use |
| mesh[21].descriptor_name | Anti-Obesity Agents |
| mesh[22].qualifier_ui | Q000627 |
| mesh[22].descriptor_ui | D003277 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | therapeutic use |
| mesh[22].descriptor_name | Contraceptives, Oral, Combined |
| mesh[23].qualifier_ui | Q000627 |
| mesh[23].descriptor_ui | D000077403 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | therapeutic use |
| mesh[23].descriptor_name | Orlistat |
| mesh[24].qualifier_ui | Q000627 |
| mesh[24].descriptor_ui | D000077270 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | therapeutic use |
| mesh[24].descriptor_name | Exenatide |
| mesh[25].qualifier_ui | Q000627 |
| mesh[25].descriptor_ui | D008687 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | therapeutic use |
| mesh[25].descriptor_name | Metformin |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D007004 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Hypoglycemic Agents |
| type | review |
| title | Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guideline |
| biblio.issue | 5 |
| biblio.volume | 25 |
| biblio.last_page | e13704 |
| biblio.first_page | e13704 |
| topics[0].id | https://openalex.org/T10390 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2743 |
| topics[0].subfield.display_name | Reproductive Medicine |
| topics[0].display_name | Ovarian function and disorders |
| topics[1].id | https://openalex.org/T12539 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9854000210762024 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2736 |
| topics[1].subfield.display_name | Pharmacology |
| topics[1].display_name | Pharmacology and Obesity Treatment |
| topics[2].id | https://openalex.org/T11146 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9801999926567078 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2712 |
| topics[2].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[2].display_name | Hormonal and reproductive studies |
| is_xpac | False |
| apc_list.value | 4940 |
| apc_list.currency | USD |
| apc_list.value_usd | 4940 |
| apc_paid.value | 4940 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4940 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7759997248649597 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780780548 |
| concepts[1].level | 4 |
| concepts[1].score | 0.765052080154419 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q424163 |
| concepts[1].display_name | Orlistat |
| concepts[2].id | https://openalex.org/C3018442814 |
| concepts[2].level | 4 |
| concepts[2].score | 0.756845235824585 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q500816 |
| concepts[2].display_name | Polycystic ovary |
| concepts[3].id | https://openalex.org/C2780533449 |
| concepts[3].level | 4 |
| concepts[3].score | 0.5972955226898193 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q417762 |
| concepts[3].display_name | Exenatide |
| concepts[4].id | https://openalex.org/C2780323712 |
| concepts[4].level | 3 |
| concepts[4].score | 0.5919720530509949 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q19484 |
| concepts[4].display_name | Metformin |
| concepts[5].id | https://openalex.org/C2781308992 |
| concepts[5].level | 4 |
| concepts[5].score | 0.5607004165649414 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2526479 |
| concepts[5].display_name | Liraglutide |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5130873918533325 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C95190672 |
| concepts[7].level | 2 |
| concepts[7].score | 0.49172547459602356 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q815382 |
| concepts[7].display_name | Meta-analysis |
| concepts[8].id | https://openalex.org/C2779284873 |
| concepts[8].level | 4 |
| concepts[8].score | 0.42274829745292664 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q419832 |
| concepts[8].display_name | Sitagliptin |
| concepts[9].id | https://openalex.org/C134018914 |
| concepts[9].level | 1 |
| concepts[9].score | 0.36467039585113525 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[9].display_name | Endocrinology |
| concepts[10].id | https://openalex.org/C2777391703 |
| concepts[10].level | 3 |
| concepts[10].score | 0.3374794125556946 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1053470 |
| concepts[10].display_name | Insulin resistance |
| concepts[11].id | https://openalex.org/C511355011 |
| concepts[11].level | 2 |
| concepts[11].score | 0.30675962567329407 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12174 |
| concepts[11].display_name | Obesity |
| concepts[12].id | https://openalex.org/C544821477 |
| concepts[12].level | 3 |
| concepts[12].score | 0.28285250067710876 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q718113 |
| concepts[12].display_name | Weight loss |
| concepts[13].id | https://openalex.org/C2777180221 |
| concepts[13].level | 3 |
| concepts[13].score | 0.24695342779159546 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q3025883 |
| concepts[13].display_name | Type 2 diabetes |
| concepts[14].id | https://openalex.org/C2779306644 |
| concepts[14].level | 2 |
| concepts[14].score | 0.21335557103157043 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q2002370 |
| concepts[14].display_name | Insulin |
| concepts[15].id | https://openalex.org/C555293320 |
| concepts[15].level | 2 |
| concepts[15].score | 0.20129001140594482 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[15].display_name | Diabetes mellitus |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7759997248649597 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/orlistat |
| keywords[1].score | 0.765052080154419 |
| keywords[1].display_name | Orlistat |
| keywords[2].id | https://openalex.org/keywords/polycystic-ovary |
| keywords[2].score | 0.756845235824585 |
| keywords[2].display_name | Polycystic ovary |
| keywords[3].id | https://openalex.org/keywords/exenatide |
| keywords[3].score | 0.5972955226898193 |
| keywords[3].display_name | Exenatide |
| keywords[4].id | https://openalex.org/keywords/metformin |
| keywords[4].score | 0.5919720530509949 |
| keywords[4].display_name | Metformin |
| keywords[5].id | https://openalex.org/keywords/liraglutide |
| keywords[5].score | 0.5607004165649414 |
| keywords[5].display_name | Liraglutide |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.5130873918533325 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/meta-analysis |
| keywords[7].score | 0.49172547459602356 |
| keywords[7].display_name | Meta-analysis |
| keywords[8].id | https://openalex.org/keywords/sitagliptin |
| keywords[8].score | 0.42274829745292664 |
| keywords[8].display_name | Sitagliptin |
| keywords[9].id | https://openalex.org/keywords/endocrinology |
| keywords[9].score | 0.36467039585113525 |
| keywords[9].display_name | Endocrinology |
| keywords[10].id | https://openalex.org/keywords/insulin-resistance |
| keywords[10].score | 0.3374794125556946 |
| keywords[10].display_name | Insulin resistance |
| keywords[11].id | https://openalex.org/keywords/obesity |
| keywords[11].score | 0.30675962567329407 |
| keywords[11].display_name | Obesity |
| keywords[12].id | https://openalex.org/keywords/weight-loss |
| keywords[12].score | 0.28285250067710876 |
| keywords[12].display_name | Weight loss |
| keywords[13].id | https://openalex.org/keywords/type-2-diabetes |
| keywords[13].score | 0.24695342779159546 |
| keywords[13].display_name | Type 2 diabetes |
| keywords[14].id | https://openalex.org/keywords/insulin |
| keywords[14].score | 0.21335557103157043 |
| keywords[14].display_name | Insulin |
| keywords[15].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[15].score | 0.20129001140594482 |
| keywords[15].display_name | Diabetes mellitus |
| language | en |
| locations[0].id | doi:10.1111/obr.13704 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S132049688 |
| locations[0].source.issn | 1467-7881, 1467-789X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1467-7881 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Obesity Reviews |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Obesity Reviews |
| locations[0].landing_page_url | https://doi.org/10.1111/obr.13704 |
| locations[1].id | pmid:38355887 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Obesity reviews : an official journal of the International Association for the Study of Obesity |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38355887 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5037880809 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Alyse S. Goldberg |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1323843004, https://openalex.org/I185261750, https://openalex.org/I2802362269 |
| authorships[0].affiliations[0].raw_affiliation_string | Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada |
| authorships[0].institutions[0].id | https://openalex.org/I2802362269 |
| authorships[0].institutions[0].ror | https://ror.org/05pr37258 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I110535807, https://openalex.org/I2802362269 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | Health Sciences Centre |
| authorships[0].institutions[1].id | https://openalex.org/I1323843004 |
| authorships[0].institutions[1].ror | https://ror.org/03wefcv03 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I1323843004 |
| authorships[0].institutions[1].country_code | CA |
| authorships[0].institutions[1].display_name | Sunnybrook Health Science Centre |
| authorships[0].institutions[2].id | https://openalex.org/I185261750 |
| authorships[0].institutions[2].ror | https://ror.org/03dbr7087 |
| authorships[0].institutions[2].type | education |
| authorships[0].institutions[2].lineage | https://openalex.org/I185261750 |
| authorships[0].institutions[2].country_code | CA |
| authorships[0].institutions[2].display_name | University of Toronto |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Alyse Goldberg |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada |
| authorships[1].author.id | https://openalex.org/A5044812417 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-3538-4038 |
| authorships[1].author.display_name | Sandro Graca |
| authorships[1].countries | GB |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210160643 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Research, Northern College of Acupuncture, York, North Yorkshire, UK |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I119664326 |
| authorships[1].affiliations[1].raw_affiliation_string | School of Health and Society, Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, West Midlands, UK |
| authorships[1].institutions[0].id | https://openalex.org/I4210160643 |
| authorships[1].institutions[0].ror | https://ror.org/0547wj766 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210160643 |
| authorships[1].institutions[0].country_code | GB |
| authorships[1].institutions[0].display_name | Northern College |
| authorships[1].institutions[1].id | https://openalex.org/I119664326 |
| authorships[1].institutions[1].ror | https://ror.org/01k2y1055 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I119664326 |
| authorships[1].institutions[1].country_code | GB |
| authorships[1].institutions[1].display_name | University of Wolverhampton |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sandro Graca |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Research, Northern College of Acupuncture, York, North Yorkshire, UK, School of Health and Society, Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, West Midlands, UK |
| authorships[2].author.id | https://openalex.org/A5101512087 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9791-8111 |
| authorships[2].author.display_name | Jing Liu |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I63525965 |
| authorships[2].affiliations[0].raw_affiliation_string | NICM Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| authorships[2].institutions[0].id | https://openalex.org/I63525965 |
| authorships[2].institutions[0].ror | https://ror.org/03t52dk35 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I63525965 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | Western Sydney University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Jing Liu |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | NICM Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| authorships[3].author.id | https://openalex.org/A5058852980 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2614-6457 |
| authorships[3].author.display_name | Vibhuti Rao |
| authorships[3].countries | AU |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I63525965 |
| authorships[3].affiliations[0].raw_affiliation_string | NICM Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| authorships[3].institutions[0].id | https://openalex.org/I63525965 |
| authorships[3].institutions[0].ror | https://ror.org/03t52dk35 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I63525965 |
| authorships[3].institutions[0].country_code | AU |
| authorships[3].institutions[0].display_name | Western Sydney University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Vibhuti Rao |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | NICM Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| authorships[4].author.id | https://openalex.org/A5071954469 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-5178-5897 |
| authorships[4].author.display_name | Selma F. Witchel |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I170201317, https://openalex.org/I4210130600 |
| authorships[4].affiliations[0].raw_affiliation_string | UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA |
| authorships[4].institutions[0].id | https://openalex.org/I4210130600 |
| authorships[4].institutions[0].ror | https://ror.org/03763ep67 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210098814, https://openalex.org/I4210130600, https://openalex.org/I4210134769 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Children's Hospital of Pittsburgh |
| authorships[4].institutions[1].id | https://openalex.org/I170201317 |
| authorships[4].institutions[1].ror | https://ror.org/01an3r305 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I170201317 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | University of Pittsburgh |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Selma Feldman Witchel |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | UPMC Children's Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania, USA |
| authorships[5].author.id | https://openalex.org/A5004409149 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-6834-4876 |
| authorships[5].author.display_name | Alexia Peña |
| authorships[5].countries | AU |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I5681781 |
| authorships[5].affiliations[0].raw_affiliation_string | Discipline of Paediatrics, Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia |
| authorships[5].institutions[0].id | https://openalex.org/I5681781 |
| authorships[5].institutions[0].ror | https://ror.org/00892tw58 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I5681781 |
| authorships[5].institutions[0].country_code | AU |
| authorships[5].institutions[0].display_name | The University of Adelaide |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Alexia Pena |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Discipline of Paediatrics, Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia |
| authorships[6].author.id | https://openalex.org/A5100385064 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-0305-5579 |
| authorships[6].author.display_name | Rong Li |
| authorships[6].countries | CN |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I20231570, https://openalex.org/I4210141942 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of OB & GYN, Reproductive Medical Center Peking University Third Hospital Beijing China |
| authorships[6].institutions[0].id | https://openalex.org/I20231570 |
| authorships[6].institutions[0].ror | https://ror.org/02v51f717 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I20231570 |
| authorships[6].institutions[0].country_code | CN |
| authorships[6].institutions[0].display_name | Peking University |
| authorships[6].institutions[1].id | https://openalex.org/I4210141942 |
| authorships[6].institutions[1].ror | https://ror.org/04wwqze12 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I4210141942 |
| authorships[6].institutions[1].country_code | CN |
| authorships[6].institutions[1].display_name | Peking University Third Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Rong Li |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of OB & GYN, Reproductive Medical Center Peking University Third Hospital Beijing China |
| authorships[7].author.id | https://openalex.org/A5047893323 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7356-4523 |
| authorships[7].author.display_name | Aya Mousa |
| authorships[7].countries | AU |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[7].affiliations[0].raw_affiliation_string | Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[7].institutions[0].id | https://openalex.org/I56590836 |
| authorships[7].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[7].institutions[0].country_code | AU |
| authorships[7].institutions[0].display_name | Monash University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Aya Mousa |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[8].author.id | https://openalex.org/A5009242728 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-6228-2654 |
| authorships[8].author.display_name | Chau Thien Tay |
| authorships[8].countries | AU |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210121067 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Diabetes and Vascular Medicine, Monash Health, Melbourne, Victoria, Australia |
| authorships[8].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[8].affiliations[1].raw_affiliation_string | Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[8].institutions[0].id | https://openalex.org/I4210121067 |
| authorships[8].institutions[0].ror | https://ror.org/02t1bej08 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I4210121067 |
| authorships[8].institutions[0].country_code | AU |
| authorships[8].institutions[0].display_name | Monash Health |
| authorships[8].institutions[1].id | https://openalex.org/I56590836 |
| authorships[8].institutions[1].ror | https://ror.org/02bfwt286 |
| authorships[8].institutions[1].type | education |
| authorships[8].institutions[1].lineage | https://openalex.org/I56590836 |
| authorships[8].institutions[1].country_code | AU |
| authorships[8].institutions[1].display_name | Monash University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Chau Thien Tay |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Diabetes and Vascular Medicine, Monash Health, Melbourne, Victoria, Australia, Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[9].author.id | https://openalex.org/A5058322616 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-1776-8791 |
| authorships[9].author.display_name | Loyal Pattuwage |
| authorships[9].countries | AU |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I56590836 |
| authorships[9].affiliations[0].raw_affiliation_string | Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[9].institutions[0].id | https://openalex.org/I56590836 |
| authorships[9].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[9].institutions[0].country_code | AU |
| authorships[9].institutions[0].display_name | Monash University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Loyal Pattuwage |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[10].author.id | https://openalex.org/A5022380857 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-7609-577X |
| authorships[10].author.display_name | Helena Teede |
| authorships[10].countries | AU |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I4210121067 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Diabetes and Vascular Medicine, Monash Health, Melbourne, Victoria, Australia |
| authorships[10].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[10].affiliations[1].raw_affiliation_string | Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[10].institutions[0].id | https://openalex.org/I4210121067 |
| authorships[10].institutions[0].ror | https://ror.org/02t1bej08 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210121067 |
| authorships[10].institutions[0].country_code | AU |
| authorships[10].institutions[0].display_name | Monash Health |
| authorships[10].institutions[1].id | https://openalex.org/I56590836 |
| authorships[10].institutions[1].ror | https://ror.org/02bfwt286 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I56590836 |
| authorships[10].institutions[1].country_code | AU |
| authorships[10].institutions[1].display_name | Monash University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Helena Teede |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Diabetes and Vascular Medicine, Monash Health, Melbourne, Victoria, Australia, Monash Centre for Health Research and Implementation, Monash University, Melbourne, Victoria, Australia |
| authorships[11].author.id | https://openalex.org/A5040461677 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-1797-7662 |
| authorships[11].author.display_name | Bülent Okan Yıldız |
| authorships[11].countries | TR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I66514158 |
| authorships[11].affiliations[0].raw_affiliation_string | Division of Endocrinology and Metabolism, Hacettepe University School of Medicine, Ankara, Turkey |
| authorships[11].institutions[0].id | https://openalex.org/I66514158 |
| authorships[11].institutions[0].ror | https://ror.org/04kwvgz42 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I66514158 |
| authorships[11].institutions[0].country_code | TR |
| authorships[11].institutions[0].display_name | Hacettepe University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Bulent O. Yildiz |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Division of Endocrinology and Metabolism, Hacettepe University School of Medicine, Ankara, Turkey |
| authorships[12].author.id | https://openalex.org/A5060627020 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-3363-9199 |
| authorships[12].author.display_name | Carolyn Ee |
| authorships[12].countries | AU |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I169541294 |
| authorships[12].affiliations[0].raw_affiliation_string | Caring Futures Institute, Flinders University, Adelaide, South Australia, Australia |
| authorships[12].affiliations[1].institution_ids | https://openalex.org/I63525965 |
| authorships[12].affiliations[1].raw_affiliation_string | NICM Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| authorships[12].affiliations[2].institution_ids | https://openalex.org/I1308309334, https://openalex.org/I63525965 |
| authorships[12].affiliations[2].raw_affiliation_string | Translational Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| authorships[12].institutions[0].id | https://openalex.org/I169541294 |
| authorships[12].institutions[0].ror | https://ror.org/01kpzv902 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I169541294 |
| authorships[12].institutions[0].country_code | AU |
| authorships[12].institutions[0].display_name | Flinders University |
| authorships[12].institutions[1].id | https://openalex.org/I1308309334 |
| authorships[12].institutions[1].ror | https://ror.org/00v807439 |
| authorships[12].institutions[1].type | facility |
| authorships[12].institutions[1].lineage | https://openalex.org/I1308309334 |
| authorships[12].institutions[1].country_code | AU |
| authorships[12].institutions[1].display_name | Translational Research Institute |
| authorships[12].institutions[2].id | https://openalex.org/I63525965 |
| authorships[12].institutions[2].ror | https://ror.org/03t52dk35 |
| authorships[12].institutions[2].type | education |
| authorships[12].institutions[2].lineage | https://openalex.org/I63525965 |
| authorships[12].institutions[2].country_code | AU |
| authorships[12].institutions[2].display_name | Western Sydney University |
| authorships[12].author_position | last |
| authorships[12].raw_author_name | Carolyn Ee |
| authorships[12].is_corresponding | True |
| authorships[12].raw_affiliation_strings | Caring Futures Institute, Flinders University, Adelaide, South Australia, Australia, NICM Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia, Translational Health Research Institute, Western Sydney University, Penrith, New South Wales, Australia |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Anti‐obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta‐analysis to inform the 2023 international evidence‐based guideline |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10390 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2743 |
| primary_topic.subfield.display_name | Reproductive Medicine |
| primary_topic.display_name | Ovarian function and disorders |
| related_works | https://openalex.org/W2418730221, https://openalex.org/W2050328567, https://openalex.org/W4298831874, https://openalex.org/W2052700785, https://openalex.org/W2086867353, https://openalex.org/W2185860084, https://openalex.org/W2059678666, https://openalex.org/W4321381004, https://openalex.org/W2004344579, https://openalex.org/W2006675803 |
| cited_by_count | 30 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 23 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 7 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1111/obr.13704 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S132049688 |
| best_oa_location.source.issn | 1467-7881, 1467-789X |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1467-7881 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Obesity Reviews |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Obesity Reviews |
| best_oa_location.landing_page_url | https://doi.org/10.1111/obr.13704 |
| primary_location.id | doi:10.1111/obr.13704 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S132049688 |
| primary_location.source.issn | 1467-7881, 1467-789X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1467-7881 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Obesity Reviews |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/obr.13704 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Obesity Reviews |
| primary_location.landing_page_url | https://doi.org/10.1111/obr.13704 |
| publication_date | 2024-02-14 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W3104254993, https://openalex.org/W4251646064, https://openalex.org/W4385799520, https://openalex.org/W4389571551, https://openalex.org/W4224024335, https://openalex.org/W1582948480, https://openalex.org/W4206803663, https://openalex.org/W4207085009, https://openalex.org/W3036813420, https://openalex.org/W2900997354, https://openalex.org/W1513555214, https://openalex.org/W4214807362, https://openalex.org/W1983583698, https://openalex.org/W2086177834, https://openalex.org/W2030843949, https://openalex.org/W2145130242, https://openalex.org/W2144589456, https://openalex.org/W2142103338, https://openalex.org/W2019085069, https://openalex.org/W4306167962, https://openalex.org/W3118615836, https://openalex.org/W4315631677, https://openalex.org/W4293426219, https://openalex.org/W3168202556, https://openalex.org/W2667417500, https://openalex.org/W2768927785, https://openalex.org/W4282831965, https://openalex.org/W2730596924, https://openalex.org/W4245067818, https://openalex.org/W4281553318, https://openalex.org/W2330618995, https://openalex.org/W4240657965, https://openalex.org/W2747812115, https://openalex.org/W3209468918, https://openalex.org/W4225986847, https://openalex.org/W2609988692, https://openalex.org/W3091243250, https://openalex.org/W3180621562, https://openalex.org/W4292263170, https://openalex.org/W3132808481, https://openalex.org/W2940562424, https://openalex.org/W2885579274, https://openalex.org/W2889521172, https://openalex.org/W3046790675, https://openalex.org/W3084893820, https://openalex.org/W4200495447, https://openalex.org/W2403512510, https://openalex.org/W2401750321, https://openalex.org/W1511363514, https://openalex.org/W4285393522, https://openalex.org/W2794964999, https://openalex.org/W2754372557, https://openalex.org/W2781586249, https://openalex.org/W2942246648, https://openalex.org/W4292809162, https://openalex.org/W2171439516, https://openalex.org/W2107080737, https://openalex.org/W2580304737, https://openalex.org/W4316466644, https://openalex.org/W2043228530, https://openalex.org/W2053031927 |
| referenced_works_count | 61 |
| abstract_inverted_index.+ | 101, 150 |
| abstract_inverted_index.2 | 144, 147, 170, 173 |
| abstract_inverted_index.= | 145, 171 |
| abstract_inverted_index.I | 143, 169 |
| abstract_inverted_index.a | 47, 199 |
| abstract_inverted_index.12 | 67 |
| abstract_inverted_index.CI | 141 |
| abstract_inverted_index.On | 71, 110 |
| abstract_inverted_index.We | 36 |
| abstract_inverted_index.be | 198 |
| abstract_inverted_index.in | 19, 61, 183, 195 |
| abstract_inverted_index.no | 112 |
| abstract_inverted_index.of | 9, 29, 180, 192 |
| abstract_inverted_index.on | 34, 52 |
| abstract_inverted_index.to | 24, 50, 85, 167 |
| abstract_inverted_index.451 | 59 |
| abstract_inverted_index.MD: | 163 |
| abstract_inverted_index.The | 190 |
| abstract_inverted_index.and | 4, 16, 41, 58, 63, 81, 99, 124 |
| abstract_inverted_index.are | 187 |
| abstract_inverted_index.did | 152 |
| abstract_inverted_index.for | 12, 87, 93, 120, 202 |
| abstract_inverted_index.not | 153 |
| abstract_inverted_index.the | 7, 26, 30, 178 |
| abstract_inverted_index.two | 94 |
| abstract_inverted_index.vs. | 97, 107 |
| abstract_inverted_index.(545 | 57 |
| abstract_inverted_index.(MD: | 138 |
| abstract_inverted_index.0.10 | 139 |
| abstract_inverted_index.18%, | 146 |
| abstract_inverted_index.2022 | 45 |
| abstract_inverted_index.2023 | 27 |
| abstract_inverted_index.67%, | 172 |
| abstract_inverted_index.COCP | 108, 151, 159 |
| abstract_inverted_index.July | 44 |
| abstract_inverted_index.PCOS | 186, 196 |
| abstract_inverted_index.This | 1 |
| abstract_inverted_index.arms | 65 |
| abstract_inverted_index.data | 176 |
| abstract_inverted_index.high | 200 |
| abstract_inverted_index.more | 133 |
| abstract_inverted_index.most | 74 |
| abstract_inverted_index.oral | 103 |
| abstract_inverted_index.pill | 105 |
| abstract_inverted_index.role | 191 |
| abstract_inverted_index.than | 128, 136 |
| abstract_inverted_index.very | 188 |
| abstract_inverted_index.were | 69, 91, 114 |
| abstract_inverted_index.with | 46, 134, 158, 185 |
| abstract_inverted_index.PCOS. | 35 |
| abstract_inverted_index.alone | 160 |
| abstract_inverted_index.blood | 131 |
| abstract_inverted_index.focus | 51 |
| abstract_inverted_index.limit | 49 |
| abstract_inverted_index.lower | 129 |
| abstract_inverted_index.newer | 53 |
| abstract_inverted_index.other | 127 |
| abstract_inverted_index.ovary | 21 |
| abstract_inverted_index.these | 193 |
| abstract_inverted_index.until | 43 |
| abstract_inverted_index.women | 184 |
| abstract_inverted_index.(PCOS) | 23 |
| abstract_inverted_index.16.26, | 168 |
| abstract_inverted_index.CINAHL | 42 |
| abstract_inverted_index.Eleven | 55 |
| abstract_inverted_index.[COCP] | 106 |
| abstract_inverted_index.agents | 11, 75, 182, 194 |
| abstract_inverted_index.future | 203 |
| abstract_inverted_index.inform | 25 |
| abstract_inverted_index.review | 3 |
| abstract_inverted_index.should | 197 |
| abstract_inverted_index.trials | 56 |
| abstract_inverted_index.update | 28 |
| abstract_inverted_index.versus | 118 |
| abstract_inverted_index.EMBASE, | 39 |
| abstract_inverted_index.Summary | 0 |
| abstract_inverted_index.agents. | 54 |
| abstract_inverted_index.alone). | 109 |
| abstract_inverted_index.between | 116 |
| abstract_inverted_index.control | 64 |
| abstract_inverted_index.effects | 179 |
| abstract_inverted_index.fasting | 130 |
| abstract_inverted_index.glucose | 132 |
| abstract_inverted_index.improve | 154 |
| abstract_inverted_index.insulin | 162 |
| abstract_inverted_index.mmol/L, | 140 |
| abstract_inverted_index.placebo | 86 |
| abstract_inverted_index.pmol/L, | 165 |
| abstract_inverted_index.−8.65 | 164 |
| abstract_inverted_index.(fasting | 161 |
| abstract_inverted_index.Medline, | 38 |
| abstract_inverted_index.Orlistat | 149 |
| abstract_inverted_index.appeared | 83 |
| abstract_inverted_index.combined | 102 |
| abstract_inverted_index.compared | 157 |
| abstract_inverted_index.efficacy | 8 |
| abstract_inverted_index.improved | 76 |
| abstract_inverted_index.limited. | 189 |
| abstract_inverted_index.orlistat | 82, 100 |
| abstract_inverted_index.outcomes | 18, 156 |
| abstract_inverted_index.possible | 92 |
| abstract_inverted_index.priority | 201 |
| abstract_inverted_index.searched | 37 |
| abstract_inverted_index.superior | 84 |
| abstract_inverted_index.syndrome | 22 |
| abstract_inverted_index.trials). | 148, 174 |
| abstract_inverted_index.−33.55 | 166 |
| abstract_inverted_index.10‐year | 48 |
| abstract_inverted_index.Guideline | 33 |
| abstract_inverted_index.PsycInfo, | 40 |
| abstract_inverted_index.Published | 175 |
| abstract_inverted_index.analyses, | 73 |
| abstract_inverted_index.evaluated | 6 |
| abstract_inverted_index.examining | 177 |
| abstract_inverted_index.exenatide | 117, 137 |
| abstract_inverted_index.hormonal, | 13 |
| abstract_inverted_index.included. | 70 |
| abstract_inverted_index.metabolic | 125, 155 |
| abstract_inverted_index.metformin | 98, 119, 135 |
| abstract_inverted_index.outcomes, | 126 |
| abstract_inverted_index.outcomes. | 89 |
| abstract_inverted_index.outcomes; | 78 |
| abstract_inverted_index.research. | 204 |
| abstract_inverted_index.(exenatide | 96 |
| abstract_inverted_index.identified | 115 |
| abstract_inverted_index.metabolic, | 15 |
| abstract_inverted_index.polycystic | 20 |
| abstract_inverted_index.systematic | 2 |
| abstract_inverted_index.biochemical | 122 |
| abstract_inverted_index.comparisons | 95 |
| abstract_inverted_index.descriptive | 72 |
| abstract_inverted_index.differences | 113 |
| abstract_inverted_index.semaglutide | 80 |
| abstract_inverted_index.0.02–0.17, | 142 |
| abstract_inverted_index.comparisons) | 68 |
| abstract_inverted_index.intervention | 62 |
| abstract_inverted_index.liraglutide, | 79 |
| abstract_inverted_index.participants | 60 |
| abstract_inverted_index.International | 31 |
| abstract_inverted_index.contraceptive | 104 |
| abstract_inverted_index.psychological | 17 |
| abstract_inverted_index.reproductive, | 14 |
| abstract_inverted_index.respectively, | 66 |
| abstract_inverted_index.anthropometric | 77, 88 |
| abstract_inverted_index.anti‐obesity | 10, 181 |
| abstract_inverted_index.Meta‐analyses | 90 |
| abstract_inverted_index.anthropometric, | 121 |
| abstract_inverted_index.meta‐analysis | 5 |
| abstract_inverted_index.Evidence‐based | 32 |
| abstract_inverted_index.meta‐analysis, | 111 |
| abstract_inverted_index.hyperandrogenism, | 123 |
| cited_by_percentile_year.max | 100 |
| cited_by_percentile_year.min | 98 |
| corresponding_author_ids | https://openalex.org/A5060627020 |
| countries_distinct_count | 6 |
| institutions_distinct_count | 13 |
| corresponding_institution_ids | https://openalex.org/I1308309334, https://openalex.org/I169541294, https://openalex.org/I63525965 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.99632797 |
| citation_normalized_percentile.is_in_top_1_percent | True |
| citation_normalized_percentile.is_in_top_10_percent | True |